Iridex gets Beck as new chief ; Boutacoff moved to CTO role
This article was originally published in Clinica
Laser devices specialist Iridex has appointed Dominik Beck, the former US chief of eye diagnostic equipment manufacturer Haag-Streit, president and CEO. Dr Beck replaces Theodore Boutacoff, who was the co-founder of Iridex and had been leading the Mountain View, California firm since its inception in 1989 to 2005, and then from 2007 to present to help turn the company around. Mr Boutacoff will remain in the company, though this time overseeing the R&D side of the business in his new role as chief technology officer. He will also leave the board of directors and be replaced by Dr Beck. Prior to joining Haag-Streit US in 2003, Dr Beck was CEO of Zurich based Ophthalmic Development Company.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.